Khalfaoui, L, Symon, F A, Couillard, S, Hargadon, B, Chaudhuri, R, Bicknell, S, Mansur, A H, Shrimanker, R, Hinks, TS C, Pavord, I D, Fowler, S J, Brown, V, McGarvey, L P, Heaney, L G, Austin, C D, Howarth, P H, Arron, J R, Choy, D F & Bradding, P 2022, ' Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma ', Allergy . https://doi.org/10.1111/all.15376 UK Medical Research Council Refractory Asthma Stratification programme (RASP-UK) 2022, ' Airway remodelling rather than cellular infiltration characterises both type2 cytokine biomarker-high and-low severe asthma ', Allergy . https://doi.org/10.1111/all.15376
American Journal of Respiratory and Critical Care Medicine Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, A H, McGarvey, L P, Heaney, L G, Fowler, S J, Bradding, P, Pavord, I D & Hinks, T S C 2021, ' Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma ', American Journal of Respiratory and Critical Care Medicine, vol. 204, no. 6, pp. 731-734 . https://doi.org/10.1164/rccm.202104-1040LE MRC UK Refractory Asthma Stratification programme (RASP-UK), Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, A H, McGarvey, L P, Heaney, L G, Fowler, S J, Bradding, P, Pavord, I D & Hinks, T S C 2021, ' Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma ', American Journal of Respiratory and Critical Care Medicine, vol. 204, no. 6, pp. 731-734 . https://doi.org/10.1164/rccm.202104-1040LE Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, A H, McGarvey, L P, Heaney, L G, Fowler, S J, Bradding, P, Pavord, I D & Hinks, T S C 2021, ' Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma ', American Journal of Respiratory and Critical Care Medicine, vol. 204, no. 6, pp. 731-734 . https://doi.org/10.1164/rccm.202104-1040le